Ubiquitin C-Terminal Hydrolase-L1 (UCH-L1) in Prediction of Computed Tomography Findings in Traumatic Brain Injury; a Meta-Analysis

F. Ramezani, Amir Bahrami-Amiri, A. Babahajian, K. Shahsavari Nia, M. Yousefifard
{"title":"Ubiquitin C-Terminal Hydrolase-L1 (UCH-L1) in Prediction of Computed Tomography Findings in Traumatic Brain Injury; a Meta-Analysis","authors":"F. Ramezani, Amir Bahrami-Amiri, A. Babahajian, K. Shahsavari Nia, M. Yousefifard","doi":"10.22037/EMERGENCY.V6I1.24028","DOIUrl":null,"url":null,"abstract":"Introduction: Ubiquitin C-terminal hydrolase-L1 (UCH-L1) is one of the promising candidates, with an acceptable diagnostic value for predicting head computed tomography (CT) scan findings. However, there has been a controversy between studies and still, there is no general overview on this. Therefore, the current systematic review and meta-analysis attempted to estimate the value of UCH-L1 in predicting intracranial lesions in traumatic brain injury. Methods: Two independent reviewers screened records from the search of four databases Medline, Embase, Scopus and Web of Science. The data were analyzed in the STATA 14.0 statistical program and the findings were reported as a standardized mean difference (SMD), summary receiver performance characteristics curve (SROC), sensitivity, specificity, and diagnostic odds ratio with 95% confidence interval (95% CI). Results: Finally, the data of 13 articles were entered into the meta-analysis. The mean serum level of UCH-L1 was significantly higher in patients with CT-positive than in TBI patients with CT negative (SMD = 1.67, 95% CI: 1.12 to 2.23, I2 = 98.1%; p <0.0001). The area under the SROC curve for UCH-L1 in the prediction of intracranial lesions after mild TBI was 0.83 (95% CI: 0.80 to 0.86). Sensitivity, specificity and diagnostic odds ratio of serum UCH-L1 was 0.97 (95% CI: 0.92 to 0.99), 0.40 (95% CI: 0.30 to 0.51) and 19.37 (95% CI: 7.25 to 51.75), respectively. When the analysis was limited to assessing the serum level of UCH-L1 within the first 6 hours after mild TBI, its sensitivity and specificity increased to 0.99 (95% CI: 0.94 to 1.0) and 0.44 (95% CI: 0.38 to 0.052), respectively. In addition, the diagnostic odds ratio of 6-hour serum level of UCH-L1 in the prediction of intracranial lesions was 680.87 (95% CI: 50.50 to 9197.97). Conclusion: Moderate level of evidence suggests that serum/plasma levels of UCH-L1 have good value in prediction of head CT findings. It was also found that evaluation of serum/plasma level of UCH-L1 within the first 6 hours following TBI would increase its predictive value. However, there is a controversy about the best cutoffs of the UCH-L1.","PeriodicalId":11681,"journal":{"name":"Emergency","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Emergency","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22037/EMERGENCY.V6I1.24028","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7

Abstract

Introduction: Ubiquitin C-terminal hydrolase-L1 (UCH-L1) is one of the promising candidates, with an acceptable diagnostic value for predicting head computed tomography (CT) scan findings. However, there has been a controversy between studies and still, there is no general overview on this. Therefore, the current systematic review and meta-analysis attempted to estimate the value of UCH-L1 in predicting intracranial lesions in traumatic brain injury. Methods: Two independent reviewers screened records from the search of four databases Medline, Embase, Scopus and Web of Science. The data were analyzed in the STATA 14.0 statistical program and the findings were reported as a standardized mean difference (SMD), summary receiver performance characteristics curve (SROC), sensitivity, specificity, and diagnostic odds ratio with 95% confidence interval (95% CI). Results: Finally, the data of 13 articles were entered into the meta-analysis. The mean serum level of UCH-L1 was significantly higher in patients with CT-positive than in TBI patients with CT negative (SMD = 1.67, 95% CI: 1.12 to 2.23, I2 = 98.1%; p <0.0001). The area under the SROC curve for UCH-L1 in the prediction of intracranial lesions after mild TBI was 0.83 (95% CI: 0.80 to 0.86). Sensitivity, specificity and diagnostic odds ratio of serum UCH-L1 was 0.97 (95% CI: 0.92 to 0.99), 0.40 (95% CI: 0.30 to 0.51) and 19.37 (95% CI: 7.25 to 51.75), respectively. When the analysis was limited to assessing the serum level of UCH-L1 within the first 6 hours after mild TBI, its sensitivity and specificity increased to 0.99 (95% CI: 0.94 to 1.0) and 0.44 (95% CI: 0.38 to 0.052), respectively. In addition, the diagnostic odds ratio of 6-hour serum level of UCH-L1 in the prediction of intracranial lesions was 680.87 (95% CI: 50.50 to 9197.97). Conclusion: Moderate level of evidence suggests that serum/plasma levels of UCH-L1 have good value in prediction of head CT findings. It was also found that evaluation of serum/plasma level of UCH-L1 within the first 6 hours following TBI would increase its predictive value. However, there is a controversy about the best cutoffs of the UCH-L1.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
泛素c端水解酶- l1 (UCH-L1)在预测颅脑损伤ct表现中的作用一个荟萃分析
泛素c端水解酶- l1 (Ubiquitin C-terminal hydroase - l1, UCH-L1)是一种很有前途的候选蛋白,在预测头部计算机断层扫描(CT)结果方面具有可接受的诊断价值。然而,研究之间一直存在争议,目前还没有一个全面的概述。因此,本系统综述和荟萃分析试图估计UCH-L1在预测外伤性脑损伤颅内病变中的价值。方法:两位独立审稿人从Medline、Embase、Scopus和Web of Science四个数据库中筛选记录。数据在STATA 14.0统计程序中进行分析,结果以标准化平均差(SMD)、总受试者表现特征曲线(SROC)、敏感性、特异性和诊断优势比(95%置信区间(95% CI))进行报告。结果:最终将13篇文献的数据纳入meta分析。CT阳性患者的平均血清UCH-L1水平显著高于CT阴性的TBI患者(SMD = 1.67, 95% CI: 1.12 ~ 2.23, I2 = 98.1%;p < 0.0001)。UCH-L1预测轻度脑外伤后颅内病变的SROC曲线下面积为0.83 (95% CI: 0.80 ~ 0.86)。血清UCH-L1的敏感性、特异性和诊断优势比分别为0.97 (95% CI: 0.92 ~ 0.99)、0.40 (95% CI: 0.30 ~ 0.51)和19.37 (95% CI: 7.25 ~ 51.75)。当分析仅限于评估轻度TBI后前6小时内的血清UCH-L1水平时,其敏感性和特异性分别增加到0.99 (95% CI: 0.94 ~ 1.0)和0.44 (95% CI: 0.38 ~ 0.052)。此外,6小时血清UCH-L1水平预测颅内病变的诊断优势比为680.87 (95% CI: 50.50 ~ 9197.97)。结论:中等水平的证据提示血清/血浆UCH-L1水平对预测头部CT表现有较好的价值。同时发现,在TBI后的前6小时内评估血清/血浆UCH-L1水平可以提高其预测价值。但是,对于UCH-L1的最佳截流装置存在争议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Emergency
Emergency EMERGENCY MEDICINE-
自引率
0.00%
发文量
1
审稿时长
8 weeks
期刊介绍: "Archives of Academic Emergency Medicine" is an international, Open Access, peer-reviewed, continuously published journal dedicated to improving the quality of care and increasing the knowledge in the field of emergency medicine by publishing high quality articles concerning emergency medicine and related disciplines. All accepted articles will be published immediately in order to increase its visibility and possibility of citation. The journal publishes articles on critical care, disaster and trauma management, environmental diseases, toxicology, pediatric emergency medicine, emergency medical services, emergency nursing, health policy and ethics, and other related topics. The journal supports the following types of articles: -Original/Research article -Systematic review/Meta-analysis -Brief report -Case-report -Letter to the editor -Photo quiz
期刊最新文献
First Impressions The Hidden Disease Association Between Renal Function and Troponin T Over Time in Stable Chronic Kidney Disease Patients. Getting the Right Stuff Ubiquitin C-Terminal Hydrolase-L1 (UCH-L1) in Prediction of Computed Tomography Findings in Traumatic Brain Injury; a Meta-Analysis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1